 |
News |
October 8, 2010, Somerset, NJ |
| Novel receives tentative approval for the generic version of Salix Pharmaceuticals, OsmoPrep®. This first-to-file product is currently in litigation and does not have a determined launch date. |
June 15, 2010, Somerset, NJ |
| Novel and Salix Pharmaceuticals arrive at settlement with respect to Novel's generic OsmoPrep® product. The parties have agreed to an early entry date for Novel's generic product in 2011. Also, Novel is to contract manufacture brand products for Salix Pharmaceuticals.
|
May 26, 2010, Somerset, NJ |
| Novel inks exclusive marketing deal with Perrigo for the pending approval of the generic version of halfLYTELY®. |
| |
May 15, 2010, Somerset, NJ |
| Novel and Salix Pharmaceuticals settle pending litigation with respect to Novel's generic MoviPrep® product. The parties have agreed to an early date for Novel's generic product in 2011. Also, Novel is to contract manufacture some brand products for Salix Pharmaceuticals. |
| Read more >> |
|
We draw our experience and wealth of knowledge to enhance the quality life of the patient through affordable medicines.
|
|
|
|
 |
Pipeline >> |
 |
Product Development >> |
 |
Facilities >> |
 |
|
| |
Novel has an aggressive pipeline, forecasting 10 to 12 ANDA approvals and product launches each year. In its first year alone, Novel filed 8 ANDAs with the USFDA. Currently...
Read more >> |
|
Novel specializes in the development and manufacturing of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms...
Read more >> |
|
Novel Laboratories is centrally located in Somerset, New Jersey, 30 miles from Newark International Airport...
Read more >> |
|
| |
| |
|
|
